ArticleAmerican journal of human genetics2021

Active site variants in STT3A cause a dominant type I congenital disorder of glycosylation with neuromusculoskeletal findings.

Matthew P Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.